Cargando…

Ruthenium-Catalyzed [2 + 2] versus Homo Diels–Alder [2 + 2 + 2] Cycloadditions of Norbornadiene and Disubstituted Alkynes: A DFT Study

[Image: see text] The ruthenium-catalyzed [2 + 2] and homo Diels–Alder [2 + 2 + 2] cycloadditions of norbornadiene with disubstituted alkynes are investigated using density functional theory (DFT). These DFT calculations provide a mechanistic explanation for observed reactivity trends with different...

Descripción completa

Detalles Bibliográficos
Autores principales: Pounder, Austin, Chen, Leanne D., Tam, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808161/
https://www.ncbi.nlm.nih.gov/pubmed/33458541
http://dx.doi.org/10.1021/acsomega.0c05499
_version_ 1783636854805889024
author Pounder, Austin
Chen, Leanne D.
Tam, William
author_facet Pounder, Austin
Chen, Leanne D.
Tam, William
author_sort Pounder, Austin
collection PubMed
description [Image: see text] The ruthenium-catalyzed [2 + 2] and homo Diels–Alder [2 + 2 + 2] cycloadditions of norbornadiene with disubstituted alkynes are investigated using density functional theory (DFT). These DFT calculations provide a mechanistic explanation for observed reactivity trends with different functional groups. Alkynyl phosphonates and norbornadiene form the [2 + 2 + 2] cycloadduct, while other functionalized alkynes afford the respective [2 + 2] cycloadduct, in excellent agreement with experimental results. The computational studies on the potential energy profiles of the cycloadditions show that the rate-determining step for the [2 + 2] cycloaddition is the final reductive elimination step, but the overall rate for the [2 + 2 + 2] cycloaddition is controlled by the initial oxidative cyclization. Two distinct mechanistic pathways for the [2 + 2 + 2] cycloaddition, cationic and neutral, are characterized and reveal that Cp*RuCl(COD) energetically prefers the cationic pathway.
format Online
Article
Text
id pubmed-7808161
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-78081612021-01-15 Ruthenium-Catalyzed [2 + 2] versus Homo Diels–Alder [2 + 2 + 2] Cycloadditions of Norbornadiene and Disubstituted Alkynes: A DFT Study Pounder, Austin Chen, Leanne D. Tam, William ACS Omega [Image: see text] The ruthenium-catalyzed [2 + 2] and homo Diels–Alder [2 + 2 + 2] cycloadditions of norbornadiene with disubstituted alkynes are investigated using density functional theory (DFT). These DFT calculations provide a mechanistic explanation for observed reactivity trends with different functional groups. Alkynyl phosphonates and norbornadiene form the [2 + 2 + 2] cycloadduct, while other functionalized alkynes afford the respective [2 + 2] cycloadduct, in excellent agreement with experimental results. The computational studies on the potential energy profiles of the cycloadditions show that the rate-determining step for the [2 + 2] cycloaddition is the final reductive elimination step, but the overall rate for the [2 + 2 + 2] cycloaddition is controlled by the initial oxidative cyclization. Two distinct mechanistic pathways for the [2 + 2 + 2] cycloaddition, cationic and neutral, are characterized and reveal that Cp*RuCl(COD) energetically prefers the cationic pathway. American Chemical Society 2020-12-18 /pmc/articles/PMC7808161/ /pubmed/33458541 http://dx.doi.org/10.1021/acsomega.0c05499 Text en © 2020 The Authors. Published by American Chemical Society This is an open access article published under a Creative Commons Non-Commercial No Derivative Works (CC-BY-NC-ND) Attribution License (http://pubs.acs.org/page/policy/authorchoice_ccbyncnd_termsofuse.html) , which permits copying and redistribution of the article, and creation of adaptations, all for non-commercial purposes.
spellingShingle Pounder, Austin
Chen, Leanne D.
Tam, William
Ruthenium-Catalyzed [2 + 2] versus Homo Diels–Alder [2 + 2 + 2] Cycloadditions of Norbornadiene and Disubstituted Alkynes: A DFT Study
title Ruthenium-Catalyzed [2 + 2] versus Homo Diels–Alder [2 + 2 + 2] Cycloadditions of Norbornadiene and Disubstituted Alkynes: A DFT Study
title_full Ruthenium-Catalyzed [2 + 2] versus Homo Diels–Alder [2 + 2 + 2] Cycloadditions of Norbornadiene and Disubstituted Alkynes: A DFT Study
title_fullStr Ruthenium-Catalyzed [2 + 2] versus Homo Diels–Alder [2 + 2 + 2] Cycloadditions of Norbornadiene and Disubstituted Alkynes: A DFT Study
title_full_unstemmed Ruthenium-Catalyzed [2 + 2] versus Homo Diels–Alder [2 + 2 + 2] Cycloadditions of Norbornadiene and Disubstituted Alkynes: A DFT Study
title_short Ruthenium-Catalyzed [2 + 2] versus Homo Diels–Alder [2 + 2 + 2] Cycloadditions of Norbornadiene and Disubstituted Alkynes: A DFT Study
title_sort ruthenium-catalyzed [2 + 2] versus homo diels–alder [2 + 2 + 2] cycloadditions of norbornadiene and disubstituted alkynes: a dft study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808161/
https://www.ncbi.nlm.nih.gov/pubmed/33458541
http://dx.doi.org/10.1021/acsomega.0c05499
work_keys_str_mv AT pounderaustin rutheniumcatalyzed22versushomodielsalder222cycloadditionsofnorbornadieneanddisubstitutedalkynesadftstudy
AT chenleanned rutheniumcatalyzed22versushomodielsalder222cycloadditionsofnorbornadieneanddisubstitutedalkynesadftstudy
AT tamwilliam rutheniumcatalyzed22versushomodielsalder222cycloadditionsofnorbornadieneanddisubstitutedalkynesadftstudy